This site uses cookies to ensure the best viewing experience for our readers.
VentureIsrael raises new $25M fund to fuel Israel’s early-stage innovators

VentureIsrael raises new $25M fund to fuel Israel’s early-stage innovators

Initial investments include AI satellites, remote health, and crime-fighting platforms. 

Meir Orbach | 14:42, 17.07.25

VentureIsrael has raised a second fund of $25 million, focused on investments in early-stage startup companies. The fund’s managing partners, Gadi Isaev and Rafael Gold, plan to invest from this new fund in approximately 20 startups, providing up to $1 million per company, with the possibility of follow-on investments. The fund will focus on companies founded by Israelis and headquartered in Israel. Its main investment areas include cybersecurity, AI infrastructure, developer tools, digital health, and future technologies that are ready for commercialization, such as quantum technologies, space tech, neuroscience, synthetic biology, and more.

The partners, Isaev and Gold, have been working together in the Israeli capital markets and VC space for over a decade. The fund’s LPs include tech founders, CTOs, and senior executives from leading startups and global tech firms. Some are managing partners at VCs based primarily in the U.S., while others come from more traditional industries such as retail, pharma, e-commerce, and manufacturing.

Gadi Isaev and Rafael Gold of VentureIsrael. Gadi Isaev and Rafael Gold of VentureIsrael. Gadi Isaev and Rafael Gold of VentureIsrael.

The second fund has already made five initial investments: Remondo, which offers groundbreaking satellite imagery at very high resolution with disruptive pricing; Sweetch, the first company to combine AI with Emotional Intelligence (EI) to create digital solutions grounded in behavioral science, backed by investors including Philips and major medical institutions; SaolaAI, a fully autonomous, maintenance-free quality control platform based on real user behavior insights, already used by some of the fund’s advisors and partners; Nuvo, an FDA-approved remote pregnancy monitoring system. Its INVU platform seamlessly measures critical biometric data of mother and fetus.

Related articles:

VentureIsrael’s first fund, worth $15 million, began operating in 2021. Notable investments from that fund include: Cydome, which develops cybersecurity solutions for the maritime industry; Wib, a cybersecurity firm acquired by F5 Networks; HEQA Security, which builds quantum physics-based encryption technology; Neurobrave, which developed a "neuro-therapeutic coach" in collaboration with Garmin, already in use by thousands of IDF soldiers; Fincom, an anti-money laundering company that secured follow-on investment from Nasdaq Ventures and Macquarie Group.

Rafael Gold, Managing Partner, VentureIsrael: "We're not afraid to take technological risks. There are hundreds of VCs in Israel, but when it comes to investing in truly complex technological segments, from space tech to synthetic biology, especially at the early stage, the number of active players narrows drastically. We're proud to be part of this ecosystem, thanks in part to our access to unique academic and technological expertise, and to support startups in their earliest days."

share on facebook share on twitter share on linkedin share on whatsapp share on mail

TAGS